In human non-small-cell lung cancer cell lines, the expression of cytoplasmic GPER1 was high [13] and treatment of non-small-cell lung cancer cell lines with GPER1 antagonists impaired tumor growth [75]. The gene discussed is GPER1; the disease is non-small cell lung carcinoma.